Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2016122631573N1Phase 3Completed
Phase 3 trial of tranexamic acid in brain neoplasm, sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Intraoperative blood loss. Started Jul 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2016122631573N1.